STOCK-BASED COMPENSATION

We recorded non-cash stock compensation expense in each period as follows:

	Three-month period ended				Nine -month period ended
	September 29 ,		September 30 ,		September 29 ,		September 30 ,
	2019		2018		2019		2018
Stock options	$	117	$	344	$	433	$	653
Restricted stock grants		42		19		86		54
Total	$	159	$	363	$	519	$	707

We have stock options outstanding from various stock-based employee compensation plans for which we record compensation cost relating to share-based payment transactions in our financial statements. As of

September 29, 2019,

there was

$924

of total unrecognized compensation cost related to outstanding stock options, which is expected to be recognized over a weighted average period of

1.4

years.

The following table summarizes stock option activity for the

nine

-month period ended

September 29, 2019:

	Number of Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (years)		Aggregate Intrinsic Value
Outstanding at January 1, 2019		1,576,087		$	6.58
Granted		282,500			8.27
Exercised		(194,720	)		4.45
Forfeited or expired		(46,082	)		7.04
Outstanding at September 29, 2019		1,617,785		$	7.12		3.38	$	3,192
Vested and expected to vest at September 29, 2019		1,518,161		$	7.05		3.21	$	3,113
Exercisable at September 29, 2019		1,095,661		$	6.29		2.31	$	2,870

The following assumptions were used to value stock options granted during the

nine

months ended

September 29, 2019:

Risk-Free Interest Rate	1.8	%
Volatility Factor	48	%
Weighted Average Expected Life (Years)	5.3
Dividends	0.0	%

The weighted average grant date fair value of options granted during the

nine

months ended

September 29, 2019

was

$3.77.

Cash received from stock option exercises under our stock-based compensation plans for the

three

-month periods ended

September 29, 2019

and

September 30, 2018

was

$388

and

$64,

respectively. Cash received from stock option exercises under our stock-based compensation plans for the

nine

-month periods ended

September 29, 2019

and

September 30, 2018

was

$866

and

$1,357,

respectively.

April 2019,

20,000

shares of restricted stock were awarded to certain of our employees at a weighted-average grant date fair value of

$11.12

per share. In

January 2018,

17,500

shares of restricted stock were awarded to certain of our employees at a weighted-average grant date fair value of

$7.16

per share. All outstanding restricted shares vest in equal annual installments over

three

years. Unrecognized compensation cost related to these restricted shares was

$188

September 29, 2019.